Loading
Latest filing published 14 May 2025 for Apimeds Pharmaceuticals US, Inc., €51k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
One trade, one date: on 14 May 2025, Jakap Koo disclosed an open-market purchase of €51k in Apimeds Pharmaceuticals US, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.